Gongwin Biopharm Holdings Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,314	10,558	14,369	20,911	36,132	31,104
Market Cap Growth	-42.24%	-26.53%	-31.28%	-42.13%	16.16%	17.15%
Enterprise Value	6,607	9,021	12,194	20,036	35,498	30,383
Last Close Price	67.80	86.10	113.50	184.50	319.50	279.64
PS Ratio	228.11	289.68	448.48	1105.50	31611.24	27212.59
PB Ratio	3.30	4.19	4.64	15.94	26.31	31.50
P/TBV Ratio	3.29	4.17	4.63	15.90	25.96	32.04
EV/Sales Ratio	181.27	247.53	380.58	1059.26	31056.74	26581.68
Debt / Equity Ratio	0.05	0.05	0.04	0.06	0.10	0.12
Net Debt / Equity Ratio	-0.67	-0.67	-0.67	-0.66	-0.70	-0.72
Net Debt / EBITDA Ratio	8.66	8.66	13.54	6.92	3.82	6.30
Net Debt / FCF Ratio	12.31	12.31	7.10	7.75	4.02	3.26
Asset Turnover	0.01	0.01	0.01	0.01	0.00	0.00
Inventory Turnover	4.63	4.63	3.01	1.27	-	-
Quick Ratio	10.25	10.25	12.27	7.58	5.80	5.34
Current Ratio	10.36	10.36	13.36	8.86	6.99	5.95
Return on Equity (ROE)	-4.31%	-4.31%	-4.17%	-7.54%	-24.75%	-12.34%
Return on Assets (ROA)	-4.19%	-4.19%	-4.14%	-5.31%	-11.66%	-6.36%
Return on Capital Employed (ROCE)	-7.90%	-7.90%	-5.10%	-9.60%	-18.20%	-11.90%
Earnings Yield	-1.37%	-1.08%	-0.57%	-0.44%	-0.81%	-0.39%
FCF Yield	-1.66%	-1.30%	-2.04%	-0.53%	-0.66%	-0.70%
Buyback Yield / Dilution	-2.70%	-2.70%	-6.64%	-1.92%	-1.44%	-4.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.